Singapore: London-based Rex Bionics has inked a partnership agreement with Chinese investment and trading company MAAB Group to introduce its lucrative medical technologies in the Chinese market. Financial terms of the deal were not disclosed.

Rex, which makes the REX Robot technology used to improve the mobility of wheelchair users, said that MAAB will handle the process of applying for regulatory approval for REX Robot in China, along with the sales, marketing and distribution of the product once this approval is secured.

Mr Crispin Simon, chief executive, Rex Bionics, said, "We are delighted to have entered into this agreement with MAAB, who have a strong team with extensive experience working with international companies, and have access to good local rehabilitation specialists."